Cationic Amphipathic LPS-Binding Peptoids for Neutralization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The development of therapeutic agents capable of neutralizing lipopolysaccharides (LPS) to improve outcomes in pathological conditions such as sepsis, autoimmune conditions, and inflammation associated with bacterial infections is challenging.
Innovation Solution
The use of LPS-binding peptoid compounds that possess cationic and amphipathic properties to bind to LPS, mimicking LPS-binding proteins and neutralizing their harmful effects, thereby preventing or decreasing the interaction of LPS with immune cells and the subsequent release of pro-inflammatory cytokines.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If therapeutic agents are developed to neutralize LPS, then pathological conditions caused by LPS can be treated, but the development process is challenging and complex
Solution Approach 1:
The patent uses peptoid compounds that mimic the structure and function of natural LPS-binding proteins. These peptoids are designed to copy the essential binding characteristics of proteins like LBP and CD14, allowing them to neutralize LPS without requiring the full complexity of natural protein systems. This copying approach enables therapeutic effectiveness while simplifying the overall system.
Solution Approach 2:
The peptoid compounds utilize cationic and amphipathic properties to achieve LPS binding. By changing the physical-chemical parameters of the therapeutic agent (using charged and hydrophobic/hydrophilic regions rather than complex protein structures), the patent achieves effective LPS neutralization with a simpler molecular design, reducing development complexity while maintaining therapeutic reliability.
2Object-affected harmful factors
If peptoid compounds with cationic and amphipathic properties are used to bind LPS, then LPS neutralization is achieved, but the molecular design requires specific structural characteristics
Solution Approach 1:
The peptoid compounds incorporate specific local structural features (cationic regions and amphipathic regions) within a relatively simple poly-N-substituted glycine backbone. This local quality approach allows the molecules to achieve complex LPS-binding functionality through localized structural characteristics rather than requiring overall molecular complexity, thus neutralizing LPS harmful effects with manageable structural design.
Solution Approach 2:
The peptoid structure combines different chemical properties (cationic groups and amphipathic regions) within a single molecular framework. This composite approach integrates multiple functional characteristics into one molecule, enabling effective LPS binding through the synergistic interaction of different structural elements without requiring a complex multi-component system.
3Reliability
If LPS-binding proteins are mimicked to neutralize LPS, then therapeutic benefits are provided, but the synthesis and production of peptoids must be optimized
Solution Approach 1:
The peptoid compounds are designed with synthetic structures that can be produced through relatively simple polymerization reactions compared to traditional protein production methods. The poly-N-substituted glycine backbone can be synthesized using standard organic chemistry techniques, making the therapeutic agents more accessible and easier to manufacture while maintaining therapeutic reliability through their designed LPS-binding properties.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The LPS-binding peptoid compounds effectively neutralize LPS, reducing its harmful effects and providing therapeutic and prophylactic benefits for a range of pathological conditions associated with LPS, including sepsis and autoimmune diseases.
Implementation Method 1
peptoid compounds that possess cationic and amphipathic properties to bind to LPS
Implementation Method 2
peptoid compounds that possess cationic and amphipathic properties to bind to LPS
Data Source
AI summary
Lipopolysaccharide-binding peptoids, and compositions and methods of use thereof, are described.